A Study in Healthy Humans to Assess the Relative Bioavailability of One Fixed-dose Combination Tablet Empagliflozin/Metformin Versus Jardiance® Tablet and Glifage® Tablet Administered Together
Clinical trial NCT05083949 · COMPLETED
Trial details
- NCT number
- NCT05083949
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2021-08-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.